Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: A review.

Hung, Sze Wan; Zhang, Ruizhe; Tan, Zhouyurong; Chung, Jacqueline Pui Wah; Zhang, Tao; Wang, Chi Chiu

Hung, Sze Wan; Zhang, Ruizhe; Tan, Zhouyurong; Chung, Jacqueline Pui Wah; Zhang, Tao; Wang, Chi Chiu.

Afiliação

Hung SW; Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong.
Zhang R; Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong.
Tan Z; Center for Reproductive Medicine, Henan Key Laboratory of Reproduction and Genetics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou.
Chung JPW; Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong.
Zhang T; Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong.
Wang CC; Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong.

Med Res Rev ; 41(4): 2489-2564, 2021 07.

Article em En | MEDLINE | ID: mdl-33948974

Assuntos

Endometriose; Preparações Farmacêuticas; Endometriose/tratamento farmacológico; Feminino; Humanos; Fosfatidilinositol 3-Quinases/metabolismo; Transdução de Sinais; Fator A de Crescimento do Endotélio Vascular

Palavras-chave

endometriosis; pathophysiology; pathways; pharmaceuticals; targets; treatments

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Endometriose Tipo de estudo: Systematic_reviews Limite: Female / Humans Idioma: En Revista: Med Res Rev Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Hong Kong

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google